Plasmid DNA encoding the respiratory syncytial virus G protein is a promising vaccine candidate
- PMID: 10725198
- DOI: 10.1006/viro.2000.0186
Plasmid DNA encoding the respiratory syncytial virus G protein is a promising vaccine candidate
Abstract
Respiratory syncytial virus (RSV) remains a major cause of severe respiratory diseases in infants, young children, and the elderly. However, development of a RSV vaccine has been hampered by the outcome of the infant trials in the 1960s with a formalin-inactivated RSV preparation. Enhanced lung disease was induced by the vaccination post-RSV exposure. Previous studies in mice primed with RSV G protein either formulated in adjuvants or delivered by recombinant vaccinia viruses have indicated that enhanced lung pathology resulted from a Th2-type host immune response against the viral G protein. However, in the present report, we have demonstrated that vaccination with plasmid vectors encoding either a full-length or a secreted G protein (DNA-G) clearly elicited balanced systemic and pulmonary Th1/Th2 cytokine responses in mice and did not induce an atypical pulmonary inflammatory reaction post-RSV challenge in cotton rats. DNA-G immunization also induced marked virus neutralizing antibody responses and protection against RSV infection of the lower respiratory tract of both mice and cotton rats. So far, only genetic immunization has been able to induce a balanced Th1/Th2 response with the RSV G protein, reminiscent of that induced by live RSV. Therefore, DNA-G is a promising immunogen for inclusion in a nucleic acid RSV vaccine.
Copyright 2000 Academic Press.
Similar articles
-
Subcellular site of expression and route of vaccination influence pulmonary eosinophilia following respiratory syncytial virus challenge in BALB/c mice sensitized to the attachment G protein.J Immunol. 1998 Sep 1;161(5):2473-80. J Immunol. 1998. PMID: 9725246
-
Alphavirus replicon particles encoding the fusion or attachment glycoproteins of respiratory syncytial virus elicit protective immune responses in BALB/c mice and functional serum antibodies in rhesus macaques.Vaccine. 2007 Oct 10;25(41):7132-44. doi: 10.1016/j.vaccine.2007.07.065. Epub 2007 Aug 21. Vaccine. 2007. PMID: 17850933
-
Induction of protective immunity in rodents by vaccination with a prokaryotically expressed recombinant fusion protein containing a respiratory syncytial virus G protein fragment.Virology. 1997 Apr 14;230(2):155-66. doi: 10.1006/viro.1997.8465. Virology. 1997. PMID: 9143271
-
Contribution of respiratory syncytial virus G antigenicity to vaccine-enhanced illness and the implications for severe disease during primary respiratory syncytial virus infection.Pediatr Infect Dis J. 2004 Jan;23(1 Suppl):S46-57. doi: 10.1097/01.inf.0000108192.94692.d2. Pediatr Infect Dis J. 2004. PMID: 14730270 Review.
-
The effect of IL-12 treatment on vaccine-enhanced illness during infection with respiratory syncytial virus.Dev Biol Stand. 1998;92:179-85. Dev Biol Stand. 1998. PMID: 9554273 Review.
Cited by
-
Single intranasal immunization with recombinant adenovirus-based vaccine induces protective immunity against respiratory syncytial virus infection.J Virol. 2008 Mar;82(5):2350-7. doi: 10.1128/JVI.02372-07. Epub 2007 Dec 19. J Virol. 2008. PMID: 18094185 Free PMC article.
-
New insights for development of a safe and protective RSV vaccine.Hum Vaccin. 2010 Jun;6(6):482-92. doi: 10.4161/hv.6.6.11562. Epub 2010 Jun 1. Hum Vaccin. 2010. PMID: 20671419 Free PMC article. Review.
-
Baculovirus-expressed virus-like particle vaccine in combination with DNA encoding the fusion protein confers protection against respiratory syncytial virus.Vaccine. 2014 Oct 7;32(44):5866-74. doi: 10.1016/j.vaccine.2014.08.045. Epub 2014 Aug 27. Vaccine. 2014. PMID: 25173478 Free PMC article.
-
Neonatal priming and infancy boosting with a novel respiratory syncytial virus vaccine induces protective immune responses without concomitant respiratory disease upon RSV challenge.Hum Vaccin Immunother. 2020 Mar 3;16(3):664-672. doi: 10.1080/21645515.2019.1671134. Epub 2019 Oct 30. Hum Vaccin Immunother. 2020. PMID: 31545125 Free PMC article.
-
Intranasal DNA Vaccine for Protection against Respiratory Infectious Diseases: The Delivery Perspectives.Pharmaceutics. 2014 Jul 10;6(3):378-415. doi: 10.3390/pharmaceutics6030378. Pharmaceutics. 2014. PMID: 25014738 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical